Clinical and biochemical predictors of efficacy of and side effects from azathioprine in patients with inflammatory bowel disease (IBD)

被引：1
|
作者：
McGovern, DP
Hussaini, H
Worthington, J
Reynolds, NJ
Shobowale-Bakre, EM
Duley, JA
Dalton, HR
机构：
[1] Royal Cornwall Hosp, Gastrointestinal Unit, Truro, Cornwall, England
[2] Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[3] Acad & St Thomas Hosp, Purine Res Lab, London, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85294-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4206
引用
收藏
页码：A788 / A788
页数：1
相关论文
共 50 条
  • [1] Clinical and biochemical predictors of efficacy to and intolerance from azathioprine in patients with inflammatory bowel disease.
    McGovern, DPB
    Hussaini, SH
    Worthington, J
    Reynolds, NJ
    Duly, J
    Dalton, HR
    GUT, 2000, 46 : A13 - A13
  • [2] Adverse effects of azathioprine in patients with inflammatory bowel disease (IBD)
    Ramirez de la Piscina, P.
    Estrada, S.
    Duca, I.
    Spicakova, K.
    Ganchegui, I.
    Calderon, M. D. R.
    Campos, A.
    Salvador, M.
    Delgado, E.
    Lopez Barbarin, J. M.
    Garcia Campos, F.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S309 - S309
  • [3] PREGNANCY IN INFLAMMATORY BOWEL-DISEASE (IBD) PATIENTS ON AZATHIOPRINE
    ALSTEAD, EM
    RITCHIE, J
    LENNARDJONES, J
    FARTHING, MJG
    CLARK, ML
    GUT, 1989, 30 (05) : A718 - A718
  • [4] Predictors of efficacy of Azathioprine for maintenance of steroid free remission: how does it differ in Indian inflammatory bowel disease (IBD) patients?
    Pal, Partha
    Banerjee, Rupa
    Reddy, D. Nageshwar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 304 - 304
  • [5] GENETIC PREDICTORS OF AZATHIOPRINE TOXICITY AND CLINICAL RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Al-Judaibi, B.
    Schwarz, U. I.
    Huda, N.
    Dresser, G. K.
    Gregor, J. C.
    Ponich, T.
    Chande, N.
    Mosli, M.
    Kim, R. B.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2016, 23 (01): : E26 - E36
  • [6] EFFICACY AND SAFETY OF AZATHIOPRINE (AZA) IN CHILDREN WITH INFLAMMATORY BOWEL-DISEASE (IBD)
    VERHAVE, M
    WINTER, HS
    GRAND, RJ
    GASTROENTEROLOGY, 1987, 92 (05) : 1682 - 1682
  • [7] The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)
    Shim, Lisa
    Eslick, Guy D.
    Simring, Alexander A.
    Murray, Henry
    Weltman, Martin D.
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (03): : 234 - 238
  • [8] Side Effects of Azathioprine in the Treatment of Chronic Inflammatory Bowel Disease
    Avallone, Eleonora V.
    Pica, Roberta
    Cassieri, Claudio
    De Carolis, Aurora
    Paoluzi, Paolo
    Vernia, Piero
    GASTROENTEROLOGY, 2009, 136 (05) : A681 - A681
  • [9] Azathioprine side effects in the treatment of chronic inflammatory bowel disease
    Lara, VG
    Calle, JLN
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2001, 93 (12) : 767 - 768
  • [10] AZATHIOPRINE DOSING IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE (IBD)
    Nguyen, T. H. M.
    Nguyen, T. V. A.
    Le, Gall C.
    Lachaux, A.
    Boulieu, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 133 - 133
12345